Stockholm3 tests improve prostate cancer screening

The use of magnetic resonance imaging (MRI) as part of the prostate cancer screening paradigm has the potential to reduce prostate cancer overdiagnoses, according to researchers at the Karolinska Institutet in Sweden. Results from the STHLM3-MRI trial, published in The New England Journal of Medicine (NEJM) in July 2021, demonstrated a reduction in overdiagnosis by using MRI-targeted biopsy over traditional biopsy methods.1 A new complementary...